Loading
Total declarations
Company
▲ Purchases (8 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Nov 2017 for ARGOS THERAPEUTICS INC, €68.0M. Read the official filing
Insider track record
Disclosed buys
8
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
8
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Pharmstandard International S.A.: trading record in brief
This profile gathers the share dealings of Pharmstandard International S.A. in Argos Therapeutics Inc. The record holds 9 filings, for trades running from 28 September 2016 to 31 October 2017.
Every open-market trade on record is a purchase: 8 purchases worth €486k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
A typical purchase (the median) is worth €55k.
On 2 November 2017 came the latest disclosure, a transaction for €68.0M in Argos Therapeutics Inc. The latest purchase dates back some time: it was published 3,660 days ago, on 13 October 2016. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Pharmstandard International S.A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
99,495 shares@ US$795.96Common StockSEC:0001140361-17-040741:0
7,164 shares@ US$4.69Common StockSEC:0000904454-16-001492:0
Canonical exit: 2 Jan 2017 (T+90)
900 shares@ US$4.85Common StockSEC:0000904454-16-001492:1
Canonical exit: 3 Jan 2017 (T+90)
2,640 shares@ US$4.81Common StockSEC:0000904454-16-001492:2
Canonical exit: 4 Jan 2017 (T+90)
21,000 shares@ US$4.73Common StockSEC:0000904454-16-001492:3
Canonical exit: 5 Jan 2017 (T+90)
30,232 shares@ US$4.71Common StockSEC:0000904454-16-001467:0
Canonical exit: 29 Dec 2016 (T+90)
11,308 shares@ US$4.70Common StockSEC:0000904454-16-001467:1
Canonical exit: 1 Jan 2017 (T+90)
28,518 shares@ US$4.54Common StockSEC:0000904454-16-001459:0
Canonical exit: 27 Dec 2016 (T+90)
15,100 shares@ US$4.60Common StockSEC:0000904454-16-001459:1
Canonical exit: 28 Dec 2016 (T+90)
9 of 9 declarations
